ADO Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ADO Antibodies, specifically targeting adenosine deaminase (ADO). Monoclonal ADO antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adenosine deaminase plays a crucial role in purine metabolism, converting adenosine to inosine, which is essential for maintaining cellular homeostasis and regulating immune responses. Dysregulation of ADO can lead to severe immunological disorders and has been implicated in various diseases, including cancer and autoimmune conditions. Understanding the function of ADO is vital for developing therapeutic strategies targeting specific pathways. ADO monoclonal antibodies enable precise detection and analysis of adenosine deaminase expression patterns across different tissue types. Researchers can effectively track ADO activity levels in various experimental conditions using multiple detection methods. Advanced visualization techniques with ADO monoclonal antibodies allow for detailed mapping of protein localization and interaction networks. Santa Cruz Biotechnology monoclonal ADO antibodies support researchers worldwide in advancing our understanding of adenosine metabolism and its role in human health.